Latest Foreign Exchange News

Page 4 of 27
Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.
Ada Torres
Ada Torres
17 Feb 2026
Godolphin Resources has released a Scoping Study for its Lewis Ponds project in NSW, revealing strong economics with a 12-year mine life and a pre-tax NPV of AUD$481 million under conservative metal prices.
Maxwell Dee
Maxwell Dee
16 Feb 2026
BlueScope Steel reported a robust first half of FY2026 with underlying EBIT soaring 81% to $557.5 million and announced a $3.00 per share shareholder return plan, while decisively rejecting a $30 per share takeover proposal.
Maxwell Dee
Maxwell Dee
16 Feb 2026
Touch Ventures Limited reported a $4.6 million net loss for 2025, driven by investment impairments and foreign exchange impacts, while appointing Gannet Capital as its new investment manager to revamp its portfolio strategy.
Claire Turing
Claire Turing
13 Feb 2026
ResMed Inc has updated the foreign exchange rate for its upcoming dividend payment to Australian CDI holders, impacting the Australian dollar amount payable per share. The dividend remains unfranked and subject to US withholding tax, with a reduced rate available under the US-Australia tax treaty.
Ada Torres
Ada Torres
13 Feb 2026
Cochlear Limited reported a modest 1% rise in HY26 sales revenue to $1.176 billion, but underlying net profit fell 9% amid slower-than-expected contract renewals for its new Nucleus Nexa implant system. The company anticipates a stronger second half and maintains full-year guidance at the lower end of its forecast.
Ada Torres
Ada Torres
13 Feb 2026
Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.
Ada Torres
Ada Torres
13 Feb 2026
Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.
Maxwell Dee
Maxwell Dee
12 Feb 2026
South32 Limited has announced a fully franked ordinary dividend of USD 0.039 per share for the six months ending December 2025, payable in multiple currencies on April 2, 2026.
Maxwell Dee
Maxwell Dee
12 Feb 2026
Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.
Claire Turing
Claire Turing
11 Feb 2026
Bravura Solutions has delivered a robust first half of FY26, posting nearly 10% revenue growth and a significant jump in profitability, while rewarding shareholders with a special dividend. The company also upgraded its full-year guidance, signalling confidence in its growth trajectory.
Sophie Babbage
Sophie Babbage
11 Feb 2026
Bravura Solutions reports robust half-year growth with nearly 10% revenue increase, a fresh leadership appointment, and strategic expansion into the UK pensions market.
Sophie Babbage
Sophie Babbage
11 Feb 2026